As CRISPR-Cas systems advance toward clinical application, it is essential to identify all the outcomes of gene-editing activity in human cells. Reports highlighting the remarkable success of homology-directed repair (HDR) in the treatment of inherited diseases may inadvertently underreport the collateral activity of this remarkable technology. We are utilizing an in vitro gene-editing system in which a CRISPR-Cas complex provides the double-stranded cleavage and a mammalian cell-free extract provides the enzymatic activity to promote non-homologous end joining, micro-homology mediated end joining, and homology-directed repair. Here, we detail the broad spectrum of gene-editing reaction outcomes utilizing Cas9 and Cas12a in combination with single-stranded donor templates of the sense and nonsense polarity. This system offers the opportunity to see the range of outcomes of gene-editing reactions in an unbiased fashion, detailing the distribution of DNA repair outcomes as a function of a set of genetic tools.
The evolution of clustered regularly interspersed palindromic repeats (CRISPR) and CRISPR-associated Cas nucleases has given researchers a novel tool with which to disable malfunctioning genes or to correct single-base mutations or small mutagenic deletions that are responsible for devastating disorders. CRISPR-Cas originated as a form of bacterial adaptive immunity1 and has been translated for use in human cells by innovative modifications2,3. The simplicity of design coupled with the efficiency of activity enables a broad spectrum of clinical development and introduction into patient populations has already begun3,4.
In mammalian cells, DNA cleavage activates DNA damage response pathways5,6, including circuitry that can lead to end modification prior to re-ligation. It is likely that non-homologous end joining (NHEJ) is the primary pathway that the cell employs to rejoin the broken template or broken chromosome7,8,9. NHEJ is generally regarded as error-prone because insertions and deletions (indels) are often generated during the process of repair10,11. There is evidence that the degree of NHEJ activities, such as end resection and processing, are much higher on transcriptionally active strands as compared to inactive strands12. This outcome might be due to the accessibility of nucleases to the transcriptionally active strand during the repair process. NHEJ and other repair pathways, including micro-homology mediated end joining (MMEJ) and/or single-strand annealing (SSA)13,14 likely account for genetic disruption and gene knockout.
When an appropriate donor DNA template is present in a gene-editing reaction, genetic information can be transferred from that template to its target following CRISPR-Cas cleavage. This process has been described as homology-directed repair (HDR), a broad-based terminology that could encompass several pathways15. These pathways share a common molecular theme where complementary DNA strands of opposite polarity are aligned in homologous register and the D-loop/joint molecular structure is resolved through replication and repair16,17,18. Most of our understanding of the DNA pairing reaction comes from fundamental studies of homologous recombination (HR) in fission yeast, budding yeast and fungus19,20. HDR is primarily active during meiosis to ensure proper segregation of chromosomes in the first-round of meiotic division21. However, somatic cells utilize various forms of HDR in order to preserve genetic integrity, assist in the repair of double-stranded breaks and help reseal single-strand DNA gaps. HDR reactions may include successful and precise insertion of a short stretch of DNA, which might be important in the repair of a mutagenic deletion within the chromosome.
In CRISPR-directed gene-editing reactions, both error-prone NHEJ and homology-directed repair compete for and act upon the same cleaved DNA site. Thus, as CRISPR-Cas systems advance toward clinical application, it becomes increasingly important to ensure that researchers and physicians can obtain all outcomes of a specific gene-editing reaction. These data will enable a more educated choice surrounding the types and amounts of genetic engineering tools to employ for the treatment of a genetic disease. For example, while high levels of single-point mutation repair have been widely reported, the accompanying secondary genetic outcomes have not been completely described. Thus, a global view of gene-editing activity is likely to be foundational as to whether to move forward with clinical application or not.
We have taken a decidedly reductionist approach to this problem by studying the mechanism of CRISPR-directed gene-editing in a system that employs a mammalian cell-free extract to drive the gene-editing reaction22,23. In this system, we can carefully control the level of reaction components and as a result, we can catalog the distribution of insertions, deletions and duplications as a function of each set of genetic tools. Here, we extend and utilize this cell-free system for the evaluation of homology-directed repair. We compare the applicability and efficiency of Cas9 and Cas12a ribonucleoprotein (RNP) complexes to execute double-stranded breaks in the target DNA in combination with single-stranded DNA donor templates of sense and nonsense polarities, to generate precisely modified DNA of target molecules. We designed our DNA donor templates to contain flanking regions containing arms of sequence homology to the target sequence and included an eight-base pair NotI restriction enzyme site, similar to that presented by Schumann et al.24. The successful outcome of precise HDR activity is measured by the insertion of the intact restriction enzyme sequence in proper orientation. Importantly, we identify and catalog the population of products associated with non-homologous end joining, precise homology-directed repair and error-prone repair. The genetic profiles of modified target molecules vary greatly in Cas9- and Cas12a-catalyzed reactions and the levels of precise homology-directed repair appear to be highly dependent on the Cas protein used and the polarity of the donor DNA template. Our system could serve as a screening tool, providing guidance for the selection of the most effective and least disruptive genetic tools for clinical protocols.
Our studies have been facilitated by an in vitro gene-editing system in which a CRISPR-Cas complex provides the double-stranded cleavage and a mammalian cell-free extract provides the enzymatic activity to promote NHEJ, MMEJ, and HDR in the presence of a donor DNA template. This in vitro system can promote DNA addition with either single- or double-stranded donor templates23. Our previous results indicate that small-fragment insertion and target site deletion are both catalyzed by the cell-free extract in a single-reaction mixture. Here, we exploit the same strategy to explore the reaction mechanics of homology-directed repair using a single-stranded DNA donor with two arms of homology to the target site.
The system is outlined in Fig. 1 and the overall reaction takes ~16 h to complete. The CRISPR–Cas complex is created through RNP assembly, which initiates DNA cleavage of the target site; the cell-free extract and donor DNA are subsequently added, and the gene-editing reaction is completed. Plasmid DNA is recovered, transformed into bacteria and re-isolated using a bacterial readout. The products of the reaction are then analyzed by DNA sequencing. For each reaction, we isolated over 30 colonies so that a true representation of the gene-editing products is presented. We define HDR as the precise insertion of the eight-base pair NotI restriction enzyme site, as compared to error-prone repair, which includes partial insertion, deletion or a combination of both, driven by NHEJ and/or MMEJ.
We have previously demonstrated that this in vitro system is fully functional on a variety of DNA targets, including eukaryotic genes23. For this study, we chose to target a plasmid containing the beta galactosidase gene, lacZ, as it provides simplified visualization of gene-editing activity through an alteration in colony color from blue to white, the typical ratio of which can be seen in Supplementary Fig. 1. We have chosen a position within the lacZ gene where genetic alterations of the coding sequence will disrupt the coding region to adversely affect protein function (Fig. 2a). To address the possibility that colonies exhibiting a blue color contain indels, likely in multiples of three, we sequenced the targeted plasmids of 118 blue colonies (Supplementary Fig. 2a–d and Supplementary Table 1). All sequences were found to contain unaltered sequence; so that to the best of our knowledge the blue/white distinction reflects either wild type (blue) or genetically modified (white) gene-editing products. This observation, of course, does not exclude the possibility that modified plasmid DNA could be harbored within random blue colonies, but we suggest that this would be a rare event. Two single-stranded DNA oligonucleotides that serve as the donor fragments are illustrated above their respective regions of complementarity in Fig. 2a; we have termed them 1364-NS to designate a donor fragment that is complementary to the sense strand and 1364-S, which is complementary to the nonsense strand. Both donor fragments are 70 bases in length and contain an eight-base NotI restriction enzyme site in the center flanked by two regions of homology; 35 bases upstream from the cut site and 27 bases downstream. There is no native NotI site within the targeted plasmid, thus HDR activity can also be screened by NotI digestion and gel electrophoresis (Supplementary Fig. 3).
CRISPR-Cas9 creates a blunt ended cut whereas the CRISPR-Cas12a complex generates staggered five base, 5′ overhangs25,26. Multiple pathways of repair are active simultaneously on a cleaved DNA molecule. In the absence of donor DNA, some form of NHEJ and/or MMEJ27 reconnects the linear plasmid template; in some cases, termini resection generates a deletion at the target site. In the presence of donor DNA, some form of homology-directed repair takes place potentially leading to precise or error-prone repair. Donor DNA serves as a template for replication and the complementary sequence is incorporated into the target molecule (Fig. 2b).
In Fig. 2c, we provide an analysis of the DNA cleavage activity of Cas9 and Cas12a complexes with increasing pmol amounts. Both nucleases display high activity and thus the target plasmid enters the repair phase of the reaction as fully linearized molecules. The incubation time for the gene-editing reaction was fixed at 15 min based on prior studies22. We did however extend the incubation time to confirm that the array of repair products generated would remain consistent; our data suggest that no notable changes in the distribution of products is observed after an extension to 90 min of reaction time (see Supplemental Fig. 4a–d).
CRISPR-Cas9 and 1364-S template
Our first combination included a CRISPR-Cas9 complex and a single-stranded donor template complementary to the nonsense strand, 1364-S. In Fig. 3a we display a snapshot of 87 bases of target DNA sequence with the localized position of the CRISPR-Cas9 cleavage site and list the genetic outcomes generated from this reaction. All the sequences presented have been selected from white colonies where gene-editing activity has taken place. For convenience, we provide Fig. 3b as an illustrative representation of the types of genetic alterations found within the population generated from this pair of gene-editing tools. From the 37 colonies sequenced, only two were found to contain a precisely inserted NotI site, the indication of precise HDR activity. The remaining colonies within the population exhibited small indels ranging from −5 bases to + 1 base. Interestingly, 28 out of 37 samples were approximately equal in distribution between deletions of 4 and 5 bases. Indel formation appears directional, with indels downstream from the cut site. The results of this experiment indicate that ~5.4% of the product molecules exhibit precise repair and NHEJ products predominate CRISPR-Cas9 reaction outcomes.
Analyses of the underlying DNA sequence generated from the precise HDR reaction confirms that the donor DNA molecule is acting as a replication template, as the inserted sequence within the targeted plasmid is the complement of the donor DNA template. Our data suggest that the insertion of complementary DNA occurs through replication extending at least four bases upstream and eight bases downstream, but does not include the entire donor strand. This mechanism of repair for CRISPR-Cas9 gene-editing was proposed by Rivera-Torres et al.28 after analyzing a wide number of gene-editing products in mammalian cells. We do not mean to suggest that this is the only mechanism and in fact direct integration of the donor strand could occur if polarity of the donor and the target strand are such that they permit direct incorporation.
CRISPR-Cas9 and 1364-NS template
Next, gene-editing reactions containing CRISPR-Cas9 and a single-stranded donor template complementary to the sense strand were tested. From this reaction, 34 bacterial colonies were analyzed. As seen in Fig. 4a, indel formation dominated the population of isolated molecules again. Figure 4b provides an illustrative representation of the product molecules. Six of the 34 colonies harbor precise repair; representing 17.6% of the overall population. Once again, small indels of −4 and −5 base deletions were found to be the most prevalent and localized downstream from the intended cut site. Our results show that HDR activity is elevated threefold when the 1364-NS donor template is coupled to CRISPR-Cas9. A preferential polarity of the donor template relative to the target site has been noted routinely in CRISPR-directed gene-editing reactions in some2,29, but not all studies.
CRISPR-Cas12a and 1364-S template
In the following series of experiments, we utilize Cas12a in place of Cas9 with the 1364-S donor template and the products are outlined in Fig. 5a, b. The complexity of gene-editing outcomes resulting from these conditions is broader with more uniquely mutated products. While most products harbored deletions ranging from −7 to −13 bases, we now observed both small and large insertions ranging from + 2 to + 26; insertions and deletions of this size were not observed in either reaction catalyzed by CRISPR-Cas9 (Figs. 3a, b and 4a, b). Six of the 32 colonies analyzed contained genetically modified templates with precise repair, thus specific HDR activity was found in 18.8% of the samples. It is important to note that this 18.8% compares favorably to the 5.4% precise HDR generated in Cas9 reactions using the 1364-S donor template.
Cas12a and 1364-NS template
The final combination of genetic tools included Cas12a and the 1364-NS donor template. Under these conditions, 34 colonies were analyzed, and the results are presented in Fig. 6a, b. Homology-directed repair activity under these conditions is seen to be highly enhanced, with precise repair found in over 65% of the colonies analyzed. The remaining products showed a wide range of indels with deletions ranging from −4 to −28 bases and insertions from +1 to +17 bases. Not only is this the highest level of homology-directed repair observed in our study, this combination also generates the widest array of error-prone genetic modifications.
A summation of the HDR activity among all four combinations described above are shown in Table 1. From these data, we conclude the combination of CRISPR-Cas12a and the 1364-NS template exhibit the highest degree of precise HDR driven by gene-editing activity within this system. Fisher’s exact test was used to evaluate the two-tailed P-value for each combination described above, we provide statistical analysis using 2 × 2 contingency tables in Supplementary Table 2. After comparing the outcomes of each, Cas12a/NS alone exhibited extremely statistically significant differences to each of the remaining combinations, confirming our belief that the best combination for carrying out CRISPR-directed gene-editing is the CRISPR-Cas12a complex and the NS strand template.
We continued to characterize the gene-editing reaction by determining the range of distances that DNA replication fills the gap of the resection at the cleavage site. To carry out this experiment, we created four NS donor strands that have alternative nucleotides at 4 and 24 bases upstream and 8 and 20 bases downstream from the CRISPR/Cas12a cut site. As the donor DNA segment provides the template for HDR, a complementary identifiable unique base would be incorporated if replication was used to fill the gap. This approach would allow us to gain some idea of the extent of resection and replication repair that occurs during the HDR reaction, proximal to the targeted insertion site. As shown in Fig. 7, the HDR reaction was successful as previously shown and in all cases the complement of the alternative base appears four bases upstream and eight bases downstream from the segment insertion site. However, the unique complementary base is not seen at 20 bases downstream or 24 bases upstream. These data suggest that DNA resection of targeted molecule extends between 4 and 24 bases upstream and 8 and 20 bases downstream and that DNA replication activity extends within this distance. We are currently further characterizing the molecular events, including replication-dependent sequence alterations that surround the HDR reaction.
We have utilized an in vitro cell-free system to elucidate the mechanism of CRISPR-directed gene-editing reactions. Our long-term objective is to define the reaction parameters that surround the efficiency with which genetic knockout and genetic knock in take place. The former relies on the process of non-homologous end joining while the latter is promoted by an aggregate of pathways known as homology-directed repair30; it is important to note that both pathways are active in the same reaction when a donor DNA template is present. The cell-free system has been shown to produce deletions, insertions, and precise and error-prone repair through several recombinational repair pathways22,23. The insertion of small fragments is likely catalyzed by the process of MMEJ27 while deletions in target DNA are likely the result of resection and NHEJ13.
Here, we have extended the functionality of the in vitro system to homology-directed repair where the objective was to precisely insert an eight-base sequence using bilateral arms of homology31,32. We designed the system so that HDR could be screened by the exact insertion of a novel NotI restriction site and found a global view of HDR events could be visualized through DNA sequencing. We identified a single-target site in plasmid DNA that could be acted upon by different CRISPR-Cas complexes, containing with Cas9 or Cas12a. Both nucleases cleave plasmid DNA to generate linearized templates rapidly. The addition of the single-stranded donor DNA in both sense and nonsense polarities and the cell-free extract catalyzes a wide array of gene-editing products, visualized in total by genetic readout. CRISPR-Cas9 complexes successfully promote precise HDR at the designated site; CRISPR-Cas9 and the 1364-S template utilized error-prone repair with a wide array of deletions usually ranging from −2 to −6 bases and consistently appearing downstream from the cut site. In several reactions, similarities were observed between the sequences of inserted fragments, this outcome may be due to faulty usage or erroneous integration of a DNA template as reported previously by Boel et al.33. CRISPR-Cas9 and the 1364-NS template produced a higher level of precise HDR activity with a similar array of indels as seen previously with the experiments utilizing the S template. The 1364-NS template may be a more amenable template for the catalysis of precise HDR because it enables a more efficient DNA synthesis to take place from a preferred replication template. We next sought to characterize the resection and replication repair activity surrounding the targeted insertion site. Our data suggest that the gap filling extends between 4 and 24 bases upstream and 8 and 20 bases downstream, which helps us understand the mechanism of action. It’s important to note, however, that the resection distance and subsequent gap filling may vary between cell types34,35. We are investigating differences among extract sources and will report on them as soon as those detailed studies are completed.
Previous data suggests that a strand bias exists in human cell gene-editing catalyzed by programmable nucleases22,29. Donor template preference is recapitulated in the in vitro system with the 1364-NS template being more effective in the generation of precise HDR. Structural hindrances throughout the native genome are likely to determine partially the effectiveness of either donor templates in catalyzing gene repair through HDR. An important study by Harmsen et al.36 found that little or no strand bias existed in a cell-based system. Thus, the influence of strand bias should be determined on a case-by-case or target by target basis. Additionally, it is possible that symmetry or asymmetry of the donor DNA fragment itself, could influence which of the target strands is more amenable to productive gene-editing activity.
Cas12a-directed reactions utilizing the 1364-S template generated precise HDR products at a frequency similar to that observed with the Cas9/1364-NS combination. The Cas12a/1364-NS combination, however, was by far the most effective in producing precise HDR reactions, equivalent to ~65.7% of all the gene-editing outcomes analyzed. Cas12a reactions also generated more extensive, complex indel formation via error-prone repair with larger insertions and deletions. Cas12a cleavage, however, creates a more active template for NHEJ and HDR activities independent of which donor template strand is used. Hyperactivity generated by Cas12a cleavage may be accounted for by the production of DNA overhangs that can act as suitable templates for pairing proteins and cellular nucleases.
One important aspect of this in vitro system is that it affords us the opportunity to visualize the wide array of genetic modifications created through the process of CRISPR-directed gene-editing in a straightforward and simple fashion. This information is important because it provides clarity surrounding the generation of unanticipated and unintended repair products created by gene-editing tools. Such information forms the basis for determining risk-benefit decisions surrounding the effectiveness of genetic engineering tools to treat human disease.
The in vitro reaction shares significant similarities with CRISPR-directed gene-editing in human cells, including the stimulation of activity by double-stranded breaks, the dependence on DNA replication for accurate repair, the importance of a proximal cut site relative to the repair site, and the existence of a strand bias. Thus, we believe that the genetic profiles reflect the modifications in intact cells to a significant degree. We cannot however, account for the influence of cell cycle, chromatin structure and the methylation status of the target site37,38,39,40,41,42 on the accuracy or efficiency of gene-editing. We recognize that the categories of outcomes we report may not always appear in each experiment and certainly represents a limitation of the assay system. As we develop a comparative in vivo system that recapitulates a simple and verifiable readout as enabled by the in vitro system, several important comparisons may be made. However, transfection efficiencies and transport of the crRNA/Cas complex to the nucleus adds an inevitable variable to all cell-based systems.
The current hypothesis of how a Cas-induced double-stranded break is repaired, using single-stranded DNA as a template, focuses on the process of single-stranded template repair (SSTR)13,18,32,36,43,44,45,46 and confirmed by Boel et al.33. A similar method known as Excision and Annealing Corrective Therapy (ExACT) has been proposed to explain cell-based results where the complement of the template becomes incorporated into the target site28. In that study, the authors found limited categories of indels in cases where HDR did not occur, providing some support for the notion that this in vitro system can be used to predict the population of outcomes of gene-editing in intact cells. All these processes contain similar features, including initialization by a double-stranded break, resection of the 3′ end to create overhangs, pairing of the overhangs with the donor DNA template, and an extension of the 3′ strand by DNA synthesis. The products of the in vitro reaction reported herein are consistent with these models, with the exception that we utilized homology arms of 35 and 27 bases upstream and downstream from the target site, respectively33. We believe that this observation reflects the capacity of the 1364-NS template to anneal to the favorable 5′ overhangs created through cleavage by Cas12a. Since Cas12a leaves staggered single-stranded DNA overhangs, that molecular structure may be more amenable to resection and single-strand pairing activities. It is important to note that our experiments have been carried out using the donor DNA template that established the in vitro gene-editing system; an asymmetric molecule with a shorter 3′ end relative to the eight-base NotI insertion site. While asymmetric donor fragments have been used successfully in cell-based gene-editing experiments31, it will be important for survey the activity of symmetrical and asymmetrical donor DNA templates in the in vitro system, studies which are currently underway.
Most cell-based systems report SSTR-based genome editing at a specific locus with high variability (0.0–30%), especially when screening human cancer cell lines32. HDR-mediated reactions also suffer from several problems, including the fact that abortive or inaccurate, imprecise HDR is a product of CRISPR-directed gene-editing reactions28,47,48,49,50,51. We can observe error-prone events on an individual basis when either Cas9 and Cas12a and the 1364-S and 1364-NS templates, all of which are represented in each reaction profile. As most investigators, we believe that the mechanistic questions surrounding human gene-editing should be further addressed as they form the foundation for human therapy. Here, we contribute to this effort by providing a more accurate view of the multiple outcomes of CRISPR-directed gene-editing in an unbiased and highly validated fashion.
Cell-free extract preparation
HEK-293 cells (American Type Cell Culture, Manassas, VA) were cultured and 8 × 106 cells were harvested and washed in cold hypotonic buffer (20 mM HEPES, 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, and 250 mM sucrose). Cells were centrifuged and re-suspended in cold hypotonic buffer without sucrose, followed by incubation on ice for 15 min before being lysed by 25 strokes of a Dounce homogenizer. Cytoplasmic fraction of enriched cell lysate was incubated on ice for 1 h and then centrifuged for 15 min at 12,000 × g, 4 °C. The supernatant was then aliquoted and stored at −80 °C. The concentration of cell-free extracts was determined using a Bradford assay.
In vitro reaction conditions
In vitro DNA cleavage reaction mixtures consisted of 500 ng (0.014 µM) of pHSG299 (Takara Bio Company, Shiga, Japan) plasmid DNA and 10 pmol RNP in a reaction buffer (100 mM NaCl, 20 mM Tris-HCl, 10 mM MgCl2 and 100 µg/ml BSA) at a final volume of 20 µl. RNP complexes consisted of purified AsCas12a or SpCas9 protein (Integrated DNA Technologies, Coralville, Iowa) and site-specific crRNA (Integrated DNA Technologies, Coralville, Iowa). Each reaction was incubated for 15 min at 37 °C, after which DNA was isolated from reaction mixtures and recovered using Select-a-Size DNA Clean & Concentrator (Zymo Research, Irvine, CA). Secondary in vitro HDR reactions included DNA recovered from the initial cleavage reaction, 100 pmol of single-stranded donor DNA (Integrated DNA Technologies, Coralville, Iowa) 1364-S 5′-GACCTGCAGGCATGCAAGCTTGGCACTGGCCGTCGGCGGCCGCTTTTACAACGTCGTGACTGGGAAAACC-3′ or 1364-NS 5′-GGTTTTCCCAGTCACGACGTTGTAAAAGCGGCCGCCGACGGCCAGTGCCAAGCTTGCATGCCTGCAGGTC-3′ and 175 µg of cell-free extract supplemented with 400 cohesive end units of Quick T4 Ligase (New England Biolabs, Ipswich, MA) in a reaction buffer (20 mM TRIS, 15 mM MgCl2, 0.4 mM DTT and 1.0 mM ATP) at a final volume of 25 µl. Each reaction was then incubated for 15 min at 37 °C. Modified plasmid DNA from the final reaction mixture was then isolated and purified during spin column recovery.
Transformation, DNA isolation, and analysis
Modified plasmid DNA recovered from in vitro reactions were transformed in 50 µl of DH5α competent E. coli (Thermo Fisher Scientific Wilmington, DE) via heat shock methodology, after which 150 µl of undiluted cells were plated on media containing X-gal and kanamycin and incubated overnight at 37 °C. Plasmid DNA was isolated from kanamycin resistant, white colonies via ZymoPURE Plasmid Miniprep Kit (Zymo Research, Irvine, CA). Modifications made to plasmid DNA were evaluated after DNA sequencing (GeneWiz, South Plainfield, NJ) and disruption patterns were assessed using SnapGene software.
PCR amplification of the lacZ gene from selected bacterial colonies generated a 547 bp amplicon using PCR Primers (Integrated DNA Technologies, Coralville, Iowa) FWD 5′-GCTTCCGGCTCGTATGTTGTGTGG-3′ and REV 5′-GTTGGACGAGTCGGAATCGCAGA-3′. The PCR conditions involved an initial denaturation of template DNA at 94 °C for 2 min, cycle denaturation at 94 °C for 30 s, primer annealing at 60 °C for 1 min, and extension at 68 °C for 30 s for 35 cycles with a hold at 68 °C for 10 min. Each PCR contained an individually picked bacterial colony, 10 µM forward and reverse primers, PCR qualified water (Quality Biological Inc., Gaithersburg, MD) and OneTaq Quick-Load Master Mix (New England Biolabs, Ipswich, MA) in a total reaction volume of 50 µl. PCR products were purified using QlAquick PCR Purification Kit (Qiagen, Hilden, Germany).
Statistics and reproducibility
Statistical analysis was done to determine the significance of precise HDR outcomes for each combination of Cas9, Cas12a nucleases, and 1364-S, 1364-NS donor templates used. For this analysis, Fisher’s exact test was used to evaluate the two-tailed P-value for each combination and the results of these analysis are provided in 2 × 2 contingency tables (see Supplementary Table 2).
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
All data generated throughout this study has been included in this article and the accompanying supplementary materials
Jiang, W. & Marraffini, L. A. CRISPR-Cas: new tools for genetic manipulations from bacterial immunity systems. Annu. Rev. Microbiol. 69, 209–228 (2015).
Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife 3, e04766 (2014).
Fellmann, C., Gowen, B. G., Lin, P. -C., Doudna, J. A. & Corn, J. E. Cornerstones of CRISPR-Cas in drug discovery and therapy. Nat. Rev. Drug Discov. 16, 89–100 (2017).
Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121–131 (2015).
Fishman-Lobell, J., Rudin, N. & Haber, J. E. Two alternative pathways of double-strand break repair that are kinetically separable and independently modulated. Mol. Cell. Biol. 12, 1292–1303 (1992).
Ceccaldi, R., Rondinelli, B. & D’Andrea, A. D. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 231, 15–24 (2016).
Roth, D. B. & Wilson, J. H. Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol. Cell. Biol. 6, 4295–4304 (1986).
Moore, J. K. & Haber, J. E. Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 2164–2173 (1996).
Gatz, S. A. et al. Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR–p53- and –Nbs1-dependent manner. Carcinogenesis 29, 519–527 (2008).
Bétermier, M., Bertrand, P. & Lopez, B. S. Is non-homologous end-joining really an inherently error-prone process? PLoS Genet. 10, e1004086 (2014).
Rodgers, K. & McVey, M. Error-prone repair of DNA double-strand breaks. J. Cell. Physiol. 231, 15–24 (2016).
Song, F. & Stieger, K. Optimizing the DNA donor template for homology-directed repair of double-strand breaks. Mol. Ther. Nucl. Acids 7, 53–60 (2017).
Jasin, M. & Haber, J. E. The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair. DNA Repair. 44, 6–16 (2016).
Bothmer, A. et al. Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus. Nat. Commun. 8, 13905 (2017).
Liang, F., Han, M., Romanienko, P. J. & Jasin, M. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc. Natl Acad. Sci. U.S.A. 95, 5172–5177 (1998).
Gamper, H. B. et al. The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. Nucl. Acids Res. 28, 4332–4339 (2000).
Drury, M. D. & Kmiec, E. B. DNA pairing is an important step in the process of targeted nucleotide exchange. Nucl. Acids Res. 31, 899–910 (2003).
Storici, F., Snipe, J. R., Chan, G. K., Gordenin, D. A. & Resnick, M. A. Conservative repair of a chromosomal double-strand break by single-strand DNA through two steps of annealing. Mol. Cell. Biol. 26, 7645–7657 (2006).
Cole-Strauss, A. et al. Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucl. Acids Res. 27, 1323–1330 (1999).
Saleh-Gohari, N. & Helleday, T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucl. Acids Res. 32, 3683–3688 (2004).
Kim, K. P. & Mirkin, E. V. So similar yet so different: The two ends of a double strand break. Mutat. Res. Mol. Mech. Mutagen. 809, 70–80 (2018).
Sansbury, B. M., Wagner, A. M., Nitzan, E., Tarcic, G. & Kmiec, E. B. CRISPR-directed in vitro gene editing of plasmid DNA catalyzed by Cpf1 (Cas12a) nuclease and a mammalian cell-free extract. Cris. J. 1, 191–202 (2018).
Sansbury, B. M. et al. CRISPR-directed gene editing catalyzes precise gene segment replacement in vitro enabling a novel method for multiplex site-directed mutagenesis. Cris. J. 2, 121–132 (2019).
Schumann, K. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc. Natl Acad. Sci. U. S. A. 112, 10437–10442 (2015).
Zetsche, B. et al. Cpf1 is a single rna-guided endonuclease of a class 2 CRISPR-cas system. Cell 163, 759–771 (2015).
Yamano, T. et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165, 949–962 (2016).
Yanik, M. et al. Development of a reporter system to explore MMEJ in the context of replacing large genomic fragments. Mol. Ther. Nucleic Acids 11, 407–415 (2018).
Rivera-Torres, N. et al. Insertional mutagenesis by CRISPR/Cas9 ribonucleoprotein gene editing in cells targeted for point mutation repair directed by short single-stranded DNA oligonucleotides. PLoS ONE. 12, e0169350 (2017).
Bialk, P. et al. Regulation of gene editing activity directed by single-stranded oligonucleotides and CRISPR/Cas9 systems. PLoS ONE. 10, e0129308 (2015).
Maggio, I. & Gonçalves, M. A. F. V. Genome editing at the crossroads of delivery, specificity, and fidelity. Trends Biotechnol. 33, 280–291 (2015).
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat. Biotechnol. 34, 339–344 (2016).
Richardson, C. D. et al. CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway. Nat. Genet. 50, 1132–1139 (2018).
Boel, A. et al. CRISPR/Cas9-mediated homology-directed repair by ssODNs in zebrafish induces complex mutational patterns resulting from genomic integration of repair-template fragments. Dis. Model. Mech. 11, dmm035352 (2018).
Brachman, E. E. & Kmiec, E. B. DNA replication and transcription direct a DNA strand bias in the process of targeted gene repair in mammalian cells. J. Cell Sci. 117, 3867–3874 (2004).
Olsen, P. A., Randøl, M., Luna, L., Brown, T. & Krauss, S. Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends. J. Gene Med. 7, 1534–1544 (2005).
Harmsen, T., Klaasen, S., van de Vrugt, H. & te Riele, H. DNA mismatch repair and oligonucleotide end-protection promote base-pair substitution distal from a CRISPR/Cas9-induced DNA break. Nucl. Acids Res. 46, 2945–2955 (2018).
Frank-Vaillant, M. & Marcand, S. Transient stability of DNA ends allows nonhomologous end joining to precede homologous recombination. Mol. Cell. 10, 1189–1199 (2002).
Brachman, E. E. & Kmiec, E. B. Gene repair in mammalian cells is stimulated by the elongation of S phase and transient stalling of replication forks. DNA Repair (Amst.). 4, 445–457 (2005).
Ferrara, L., Engstrom, J. U., Schwartz, T., Parekh-Olmedo, H. & Kmiec, E. B. Recovery of cell cycle delay following targeted gene repair by oligonucleotides. DNA Repair (Amst.). 6, 1529–1535 (2007).
Engstrom, J. U. & Kmiec, E. B. DNA Replication, cell cycle progression and the targeted gene repair reaction. Cell Cycle 7, 1402–1414 (2008).
Engstrom, J. U., Suzuki, T. & Kmiec, E. B. Regulation of targeted gene repair by intrinsic cellular processes. BioEssays 31, 159–168 (2009).
Brandsma, I. & Gent, D. C. Pathway choice in DNA double strand break repair: observations of a balancing act. Genome Integr. 3, 9 (2012).
Renaud, J. B. et al. Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases. Cell Rep. 14, 2263–2272 (2016).
Davis, L. & Maizels, N. Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair. Proc. Natl Acad. Sci. U.S.A. 111, E924–E932 (2014).
Davis, L. & Maizels, N. Two distinct pathways support gene correction by single-stranded donors at DNA nicks. Cell Rep. 17, 1872–1881 (2016).
Kan, Y., Ruis, B., Takasugi, T. & Hendrickson, E. A. Mechanisms of precise genome editing using oligonucleotide donors. Genome Res. 27, 1099–1111 (2017).
Gratz, S. J. et al. Genome engineering of drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194, 1029–1035 (2013).
Hwang, W. Y. et al. Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS ONE 8, e68708 (2013).
Zu, Y. et al. TALEN-mediated precise genome modification by homologous recombination in zebrafish. Nat. Methods 10, 329–331 (2013).
Hoshijima, K., Jurynec, M. J. & Grunwald, D. J. Precise editing of the zebrafish genome made simple and efficient. Dev. Cell. 36, 654–667 (2016).
Paix, A. et al. Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks. Proc. Natl Acad. Sci. 114, E10745–E10754 (2017).
This work was supported by a grant from the Binational Industrial Research Development (BIRD) Foundation (1558). We are grateful to the other members of the Kmiec laboratory for their input on this manuscript.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sansbury, B.M., Hewes, A.M. & Kmiec, E.B. Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair. Commun Biol 2, 458 (2019). https://doi.org/10.1038/s42003-019-0705-y
This article is cited by
Trait Improvement of Solanaceae Fruit Crops for Vertical Farming by Genome Editing
Journal of Plant Biology (2023)
Homology directed correction, a new pathway model for point mutation repair catalyzed by CRISPR-Cas
Scientific Reports (2022)
Exon skipping induced by CRISPR-directed gene editing regulates the response to chemotherapy in non-small cell lung carcinoma cells
Gene Therapy (2022)
Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing
Gene Therapy (2022)
Directed evolution in mammalian cells
Nature Methods (2021)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.